Celgene, Bristol-Myers set $2.2 billion termination fee for their mega deal


Celgene Corp and Bristol-Myers Squibb Co will have to pay $2.2 billion if either of the drugmakers walks away from their $74 billion merger announced on Thursday, according to a regulatory filing.